Navigasjon

  • Hopp til innhold
NTNU Hjemmeside NTNU Hjemmeside

ntnu.no

  • Studier
    • Studere på NTNU
    • Finn studieprogram
    • Søke opptak
    • Videreutdanning og deltid
    • Forkurs og oppfriskning
  • Studentliv
    • Student i Gjøvik
    • Student i Trondheim
    • Student i Ålesund
  • Forskning og innovasjon
    • Forskning
    • Innovasjon
    • Satsingsområder
    • Toppforskning
    • Ekspertlister
    • Ph.d.
  • Om NTNU
    • Fakulteter og institutter
    • Sentre
    • Bibliotek
    • Kart
    • Ledige stillinger
    • Arrangement
    • Nyheter
    • Kontakt oss
    • Om NTNU
  1. Ansatte

Språkvelger

English

Kristin Toftaker Killingberg

Last ned pressefoto
Last ned pressefoto
Foto:

Kristin Toftaker Killingberg

Overlege kreftklinikken , Førsteamanuensis
Institutt for klinisk og molekylær medisin
Fakultet for medisin og helsevitenskap
MH fakultetsadministrasjon

kristin.t.killingberg@ntnu.no
47386257 Kunnskapssenteret, Øya
Om Forskning Publikasjoner Formidling

Om

CV

Overlege ved Kreftklinikken, St. Olavs hospital. Spesialist i allmennmedisin og onkologi.

PhD i medisin med tema strålebehandling av småcellet lungekreft. Forsker, førsteamanuensis. 

Koordinator for praktisk klinisk eksamen ved medisinstudie NTNU (OSKE ). 

Utdanning:

  • Cand. med., NTNU 1996
  • Spesialist i allmennmedisin 2008
  • Spesialist i behandling av kreftsykdommer,Onkolog, St. Olavs Hospital 2017
  • Doktorgrad (PhD i klinisk medisin), NTNU 2023

Forskningsinteresser:

  • Lungekreft, spesielt småcellet lungekreft
  • Strålebehandling av lungekreft 
  • Eldre og kreft
  • Klinisk relevante biomarkører

 

Kompetanseord

  • Eldre Kreftpasienter
  • Helserelatert livskvalitet
  • Klinisk kreftforskning
  • Lungekreft
  • Radioterapi / strålebehandling

Forskning

Hovedaktiviteten er kliniske intervensjonsstudier på lungekreft, spesielt småcellet lungekreft. Annen klinisk forskning inkluderer studier på helserelatert livskvalitet, kreft hos eldre.  Den andre hovedsatsningen er translasjonsforskning basert på biologisk materiale som er samlet inn gjennom de klinsiske studiene og vår lungekreftbiobank. 

Publikasjoner

  • Kronologisk
  • Etter kategori
  • Alle publikasjoner i Nasjonalt vitenarkiv (NVA)

2025

  • Grønberg, Miriam; Aanerud, Marianne; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning. (2025) Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT). Lung Cancer
    Vitenskapelig artikkel
  • Graabak, Gustav; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker. (2025) Changes in use of radiotherapy for lung cancer – A Norwegian population-based study from 2000 until 2020. Lung Cancer
    Vitenskapelig artikkel
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Bjaanæs, Maria Moksnes; Brustugun, Odd Terje; Madebo, Tesfaye; Langer, Seppo Wang; Risumlund, Signe Leonora; Schytte, Tine; Helbekkmo, Nina. (2025) High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial. Journal of Thoracic Oncology
    Vitenskapelig artikkel

2024

  • Graabak, Gustav; Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2024) Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC. JTO Clinical and Research Reports
    Vitenskapelig artikkel
  • Levin, Nina; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Danielsen, Signe; Grønberg, Bjørn Henning. (2024) Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics
    Vitenskapelig artikkel
  • Taranova, Evgenia; Aanerud, Marianne; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2024) Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC. JTO Clinical and Research Reports
    Vitenskapelig artikkel

2023

  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Kirkevold, Øyvind; Slaaen, Marit. (2023) Twice-daily thoracic radiotherapy in limited stage small-cell lung cancer. Norges teknisk-naturvitenskapelige universitet
    Doktoravhandling
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). American Journal of Clinical Oncology
    Konferanseabstract
  • Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien. (2023) Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC. Journal of Thoracic Oncology
    Vitenskapelig artikkel
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Bjaanæs, Maria Moksnes; Madebo, Tesfaye; Schytte, Tine; Langer, Seppo Wang; Risumlund, Signe Leonora; Helbekkmo, Nina; Neumann, Kirill. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). Journal of Clinical Oncology
    Konferanseabstract
  • Taranova, Evgenia; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Slaaen, Marit; Aanerud, Marianne. (2023) Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT). Journal of Clinical Oncology
    Konferanseabstract

2022

  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan; Hornslien, KJERSTI; Madebo, Tesfaye; Schytte, Tine; Risum, Signe. (2022) Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer
    Vitenskapelig artikkel
  • Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2022) Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer. Clinical Medicine Insights: Oncology
    Vitenskapelig artikkel
  • Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. Radiotherapy and Oncology
    Konferanseabstract
  • Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Killingberg, Kristin Toftaker; Sandvei, Marie Søfteland. (2022) Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC. Healthcare
    Vitenskapelig artikkel

2021

  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; Hornslien, KJERSTI; Madebo, Tesfaye; Langer, Seppo Wang; Schytte, Tine; Nyman, Jan; Risum, Signe. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology
    Vitenskapelig artikkel

2020

  • Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje; Fløtten, Øystein; Helbekkmo, Nina; Hornslien, Kjersti; Madebo, Tesfaye. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica
    Vitenskapelig artikkel

Tidsskriftspublikasjoner

  • Grønberg, Miriam; Aanerud, Marianne; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning. (2025) Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT). Lung Cancer
    Vitenskapelig artikkel
  • Graabak, Gustav; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker. (2025) Changes in use of radiotherapy for lung cancer – A Norwegian population-based study from 2000 until 2020. Lung Cancer
    Vitenskapelig artikkel
  • Graabak, Gustav; Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2024) Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC. JTO Clinical and Research Reports
    Vitenskapelig artikkel
  • Levin, Nina; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Danielsen, Signe; Grønberg, Bjørn Henning. (2024) Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics
    Vitenskapelig artikkel
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). American Journal of Clinical Oncology
    Konferanseabstract
  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan; Hornslien, KJERSTI; Madebo, Tesfaye; Schytte, Tine; Risum, Signe. (2022) Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer
    Vitenskapelig artikkel
  • Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2022) Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer. Clinical Medicine Insights: Oncology
    Vitenskapelig artikkel
  • Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien. (2023) Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC. Journal of Thoracic Oncology
    Vitenskapelig artikkel
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Bjaanæs, Maria Moksnes; Madebo, Tesfaye; Schytte, Tine; Langer, Seppo Wang; Risumlund, Signe Leonora; Helbekkmo, Nina; Neumann, Kirill. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). Journal of Clinical Oncology
    Konferanseabstract
  • Taranova, Evgenia; Aanerud, Marianne; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2024) Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC. JTO Clinical and Research Reports
    Vitenskapelig artikkel
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; Hornslien, KJERSTI; Madebo, Tesfaye; Langer, Seppo Wang; Schytte, Tine; Nyman, Jan; Risum, Signe. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology
    Vitenskapelig artikkel
  • Taranova, Evgenia; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Slaaen, Marit; Aanerud, Marianne. (2023) Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT). Journal of Clinical Oncology
    Konferanseabstract
  • Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. Radiotherapy and Oncology
    Konferanseabstract
  • Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje; Fløtten, Øystein; Helbekkmo, Nina; Hornslien, Kjersti; Madebo, Tesfaye. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica
    Vitenskapelig artikkel
  • Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Bjaanæs, Maria Moksnes; Brustugun, Odd Terje; Madebo, Tesfaye; Langer, Seppo Wang; Risumlund, Signe Leonora; Schytte, Tine; Helbekkmo, Nina. (2025) High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial. Journal of Thoracic Oncology
    Vitenskapelig artikkel
  • Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Killingberg, Kristin Toftaker; Sandvei, Marie Søfteland. (2022) Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC. Healthcare
    Vitenskapelig artikkel

Studentoppgave eller avhandling

  • Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Kirkevold, Øyvind; Slaaen, Marit. (2023) Twice-daily thoracic radiotherapy in limited stage small-cell lung cancer. Norges teknisk-naturvitenskapelige universitet
    Doktoravhandling

Formidling

2025

  • Konferanseposter
    Killingberg, Kristin Toftaker; Sætrom, Pål; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Figueiredo, Filipe Carlos Pereira dos Reis. (2025) Serum microRNAs are associated with treatment response and disease progression in limited stage small cell lung cancer. IASLC Hot topic in basic and translational science small cell lung cancer
  • Foredrag
    Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Sandvei, Marie Søfteland. (2025) Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC)​. ASCO 2025
  • Konferanseposter
    Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Oliveira, Rafael S.. (2025) Subtyping Small Cell Lung Cancer Reveals Inflammatory Subtypes with Improved Radiosensitivity and Chemoradiotherapy Outcomes. IASLC Hot topic in basic and translational science small cell lung cancer
  • Konferanseposter
    Grønberg, Miriam; Killingberg, Kristin Toftaker; Aanerud, Marianne; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2025) Time Until Treatment, Treatment Time, and Outcomes of Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. European Lung Cancer Congress 2025

2023

  • Foredrag
    Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). ASCO 2023
  • Foredrag
    Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2023) Dose-response of acute esophagitis for limited stage small cell lung cancer - Data from a randomized phase II trial. BiGART

2022

  • Foredrag
    Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. ESTRO 2022

2019

  • Konferanseposter
    Stokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier; Killingberg, Kristin Toftaker; Fluge, Sverre; Hornslien, KJERSTI; Grønberg, Bjørn Henning. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC

NTNU – Norges teknisk-naturvitenskapelige universitet

  • For ansatte
  • |
  • For studenter
  • |
  • Innsida
  • |
  • Canvas

Studere

  • Om studier
  • Studieprogram
  • Emner
  • Videreutdanning
  • Karriere

Aktuelt

  • Nyheter
  • Arrangement
  • Jobbe ved NTNU

Om NTNU

  • Om NTNU
  • Bibliotek
  • Strategi
  • Forskning
  • Satsingsområder
  • Innovasjon
  • Organisasjonskart
  • Utdanningskvalitet

Kontakt

  • Kontakt oss
  • Finn ansatte
  • Spør en ekspert
  • Pressekontakter
  • Kart

NTNU i tre byer

  • NTNU i Gjøvik
  • NTNU i Trondheim
  • NTNU i Ålesund

Om nettstedet

  • Bruk av informasjonskapsler
  • Tilgjengelighetserklæring
  • Personvern
  • Ansvarlig redaktør
Facebook Instagram Linkedin Snapchat Tiktok Youtube
Logg inn
NTNU logo